American Society of Clinical Oncology

SHERPA: White

People

  1. Slovin
    Slovin
  2. Scher
    Scher
  3. Morris
    Morris
  4. Danila
    Danila
  5. Abida
    Abida
  6. Rathkopf
    Rathkopf
  7. Reuter
    Reuter
  8. Solit
    Solit
  9. Autio
    Autio
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (12)
  2. Genitourinary Oncology Service (12)
  3. Hematologic Malignancies, Division of (12)
  4. Sloan Kettering Institute Postdocs (12)
  5. Solid Tumor Oncology Division (12)
  6. GSK Faculty (8)
  7. Epidemiology and Biostatistics (6)
  8. Center for Pancreatic Cancer Research (5)
  9. Human Oncology and Pathogenesis Program (5)
  10. Radiology, Department of (5)
Search Within
  1. "Susan Slovin"
  2. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (2)
Groups
  1. Department of Medicine (12)
  2. Genitourinary Oncology Service (12)
  3. Hematologic Malignancies, Division of (12)
  4. Sloan Kettering Institute Postdocs (12)
  5. Solid Tumor Oncology Division (12)
  6. GSK Faculty (8)

More Groups

People
  1. Susan Slovin (12)
  2. Howard Scher (11)
  3. Michael Morris (10)
  4. Dana Rathkopf (9)
  5. Daniel Danila (9)
  6. Wassim Abida (7)

More People

Years
  1. 2022 (2)
  2. 2020 (3)
  3. 2019 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. JCO Precision Oncology (2)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Dorff, T. B.; Falchook, G. S.; Wei, X. X.; Gao, X.; McKay, R. R.; Oh, D. Y.; Wibmer, A. G.; Spear, M. A.; McCaigue, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Meeting Abstract

    Keegan, N. M.; Vasselman, S. E.; Barnett, E.; Nweji, B.; Carbone, E.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Changes in Ki-67 and cleaved caspase-3 (CC3) with short term androgen deprivation therapy (ADT) prior to prostatectomy as part of a trial in intermediate and high-risk prostate cancer (PC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Chen, Y. B.; Autio, K. A.; Carver, B. S.; Slovin, S. F.; Danila, D. C.; Scher, H. I.; Touijer, K. A.; Rathkopf, D. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations
    Journal Article

    Mota, J. M.; Barnett, E.; Nauseef, J. T.; Nguyen, B.; Stopsack, K. H.; Wibmer, A.; Flynn, J. R.; Heller, G.; Danila, D. C.; Rathkopf, D.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes
    Meeting Abstract

    Mota, J. M.; Barnett, E.; Nauseef, J.; Stopsack, K. H.; Wibmer, A. G.; Danila, D. C.; Rathkopf, D. E.; Slovin, S. F.; Kantoff, P. W.; Scher, H. I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Meeting Abstract

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Carbone, E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Meeting Abstract

    Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Brennan, R.; Armenia, J.; Curtis, K. R.; Gopalan, A.; Arcila, M. E.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save